FY2025 Earnings Forecast for Humana Issued By Zacks Research

Humana Inc. (NYSE:HUM) – Investment analysts at Zacks Research decreased their FY2025 earnings estimates for shares of Humana in a report issued on Tuesday, February 25th. Zacks Research analyst D. Chatterjee now forecasts that the insurance provider will earn $16.24 per share for the year, down from their prior estimate of $16.65. The consensus estimate for Humana’s current full-year earnings is $16.47 per share. Zacks Research also issued estimates for Humana’s Q1 2026 earnings at $6.07 EPS, Q3 2026 earnings at $2.98 EPS and FY2027 earnings at $18.63 EPS.

Other research analysts have also recently issued research reports about the stock. Barclays boosted their price objective on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Piper Sandler boosted their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial boosted their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Nineteen analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Stock Performance

Shares of HUM stock opened at $261.49 on Thursday. The stock has a market cap of $31.55 billion, a PE ratio of 26.28, a price-to-earnings-growth ratio of 2.05 and a beta of 0.56. The stock has a 50-day moving average of $270.64 and a 200-day moving average of $287.87. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana has a one year low of $213.31 and a one year high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.35%. Humana’s payout ratio is presently 35.58%.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.32% of the company’s stock.

Institutional Trading of Humana

A number of large investors have recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV lifted its stake in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in shares of Humana in the third quarter valued at approximately $31,000. Your Advocates Ltd. LLP lifted its position in shares of Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the last quarter. FPC Investment Advisory Inc. bought a new position in shares of Humana during the 4th quarter worth approximately $27,000. Finally, Centricity Wealth Management LLC acquired a new position in shares of Humana during the 4th quarter worth approximately $30,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.